Hassan Hemeg

Dr. Hassan A. Hemeg completed his Masters in Pathological Science at the Sheffield University, UK and Ph.D. from King Abdulaziz University, Jeddah, Saudi Arabia. He has earned several honors such as Fellow of Institute of Biomedical Science, UK and Certified Canadian Accreditation Specialist for Health Care Facilities. He acquired training in Microbiology from Sheffield and Bristol Universities, U.K. and U.S. Department of Labor, Occupational Safety and Health Administration. He is a member, Secretary and Chairman of several Committees. His research interest is in the field of antimicrobial resistance. He has published several papers in Journals of International repute and is co-editor of few books. Presently, he is an Assistant Professor in Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Taibah University, Madina, Saudi Arabia where he also served as Vice Dean.

1books edited

1chapters authored

Latest work with IntechOpen by Hassan Hemeg

Staphylococcus aureus strains are an important medical infectious agent that causes a wide range of pathogeneses starting from colonization of the skin and mucosal surface to severe pathogenic effects such as septicemia. The mortality and morbidity from this pathogen are challenging issues for the healthcare premises. Methicillin Resistant Staphylococcus aureus strains (MRSA) are causing severe infections due to the genes that are resistant to several antibiotics including methicillin, aminoglycosides, and others. Recently, there have been several reports related to failure of treatment plans caused by MRSA that led to Vancomycin Intermediate Staphylococcus aureus strains (VISA) or, in sporadic cases, resistance to the drug of choice. This book highlights the new areas for the treatment of MRSA using natural products. The implementation of specific products produced by this organism can help the scientist to obtain a new window for treatments such as anticancer chemotherapy, antioxidants, etc.

Go to the book